Corvus Pharmaceuticals
CRVS
CRVS
102 hedge funds and large institutions have $307M invested in Corvus Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
11% more funds holding
Funds holding: 92 → 102 (+10)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5.36% less ownership
Funds ownership: 61.29% → 55.93% (-5.4%)
Holders
102
Holding in Top 10
2
Calls
$2.28M
Puts
$1.62M
Top Buyers
| 1 | +$2.42M | |
| 2 | +$1.75M | |
| 3 | +$1.41M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.15M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$979K |
Top Sellers
| 1 | -$3.03M | |
| 2 | -$3.01M | |
| 3 | -$1.42M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$807K |
| 5 |
Renaissance Technologies
New York
|
-$661K |